Superbug surcharge: The economics of MDROs and HAIs

Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) threaten patient health and impose significant financial burdens on healthcare systems, necessitating extended hospital stays and costly treatments. Consequently, there is an urgent need for proactive solutions to combat these escalating threats.

This infographic illustrates the financial toll in the U.S., Europe, and globally, while highlighting diagnostic innovations that help reduce risks, improve patient care, and strengthen antimicrobial stewardship.